(55 days)
ViTelCare™ Turtle 400 Patient Monitoring System is intended to be a communication tool for an in-home patient that acquires, accumulates, and transmits vital signs information, selfassessment of physical condition, and other physiological data to a healthcare practitioner located remotely from the patient. The patient information is received and stored on the MedVizer™ ViTelCare Call Center where a qualified healthcare practitioner can review the patient information and data. The communication connectivity between patient and healthcare practitioner is via a standard public telecommunications utility to the Internet. Decisions concerning diagnosis and treatment are to be performed by qualified healthcare professionals.
The ViTelCare™ Turtle 400 Patient Monitoring System is a PC based Telemedicine system adapted to the collection, management, and communication of patient monitoring data from home and group care environments.
The provided text is a 510(k) summary for the ViTelCare™ Turtle 400 Patient Monitoring System, and a letter from the FDA regarding its substantial equivalence. This document primarily focuses on describing the device, its intended use, and its substantial equivalence to a predicate device.
There is no detailed information provided in the given text regarding specific acceptance criteria, performance data, or a study that proves the device meets those criteria.
The document states: "The ViTelCare™ Turtle 400 Patient Monitoring System is virtually identical to the ViTelCare™ Patient Monitoring System. There are no technical differences with any implications for safety and effectiveness." This indicates that the device's acceptance was based on its substantial equivalence to a previously cleared device (K040581), rather than a new performance study with specific metrics.
Therefore, I cannot provide the requested information in a table format or answer the detailed questions about sample sizes, expert qualifications, adjudication methods, MRMC studies, or standalone performance. The document explicitly states that the device is "substantially equivalent" to a predicate device, implying that its performance is assumed to be similar to that of the predicate device, and no new performance data is presented in this summary.
Key takeaway from the provided document:
The device's acceptance is based on demonstrating substantial equivalence to a predicate device (ViTelCare™ Patient Monitoring System, K040581), not on new performance studies with specific acceptance criteria.
{0}------------------------------------------------
K043368
p.1/2
FEB = 1 2005
Attachment 4
510(k) Summary As Required by 807.92 For ViTelCare™ Turtle 400 Patient Monitoring System Prepared on November 22nd, 2004
Submitted By: ViTel Net 8201 Greensboro Drive, Suite 600 McLean, VA 22102
Tel. (703) 448-0999 Fax: (703) 749-9559
- Contact Person: Allen Izadpanah President and Chief Executive Officer
Device Trade Name:ViTeICare™ Turtle 400 Patient Monitoring System
Common Name: Turtle 400 Patient Monitoring System
Classification: Not Classified
ViTelCare™ Patient Monitoring System (K040581) Predictive Device:
- Manufactured By: ViTel Net 221 Elizabeth Street Utica, NY 13501
Description of The Device: The ViTelCare™ Turtle 400 Patient Monitoring System is a PC based Telemedicine system adapted to the collection, management, and communication of patient monitoring data from home and group care environments.
Intended Use For This Device: Indications for Use: ViTelCare™ Turtle 400 Patient Monitoring System is intended to be a communication tool for an in-home patient that acquires, accumulates, and transmits vital signs information, selfassessment of physical condition, and other physiological data to a healthcare practitioner located remotely from the patient. The patient information is received and stored on the MedVizer™ ViTelCare Call Center where a qualified healthcare practitioner can review the patient information and data. The communication connectivity between patient and healthcare practitioner is via a standard public telecommunications utility to the Internet. Decisions concerning
{1}------------------------------------------------
Image /page/1/Picture/0 description: The image shows handwritten text on a white background. The text at the top reads "0-3363", with the first character possibly being "K". Below this, the text "p 2/2" is written, indicating a page number. The handwriting appears somewhat rough and uneven.
diagnosis and treatment are to be performed by qualified healthcare professionals.
Substantial Equivalence to Predicate Device: The ViTelCare™ Turtle 400 Patient Monitoring System is virtually identical to the ViTelCare™ Patient Monitoring System. There are no technical differences with any implications for safety and effectiveness. The labeling of ViTelCare™ Turtle 400 Patient Monitoring System includes extensive protocols for monitoring patients with medical conditions. These have been derived from guidelines published by the VA, DoD, and other national organizations.
{2}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Image /page/2/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles an abstract human figure or a caduceus, which is a symbol often associated with healthcare.
FEB - 1 2005
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Visual Telecommunications Network c/o Mr. Allen Izadpanah 8201 Greensboro Drive Suite 600 McLean VA 22102
Re: K043368
Trade Name: VitelCare™ Turtle Patient Monitoring System Regulation Number: 21 CFR 870.2300 Regulation Number: 21 CFN 870.2500
Regulation Name: Physiological Patient Monitor (without arrhythmia detection or alarms) Regulatory Class: II (two) Product Code: MWI Dated: January 11, 2005 Received: January 12, 2005
Dear Mr. Izadpanah:
We have reviewed your Section 510(k) premarket notification of intent to market the device ti we nave reviewed your Section 9 rotty premained is substantially equivalent (for the indications
referenced above and have determined the device is substantial in interstate for use stated in the enclosure) the development of the devices marketed in interstate for use stated in the encrosule) to regally manation in the Medical Device Amendments, or to
commerce prior to May 28, 1976, the enactment date of the Enderel Food. Drug commerce prior to May 20, 1970, the encordance with the provisions of the Federal Food, Drug, devices that have been icclassified in accessor who a premarket approval application (PMA).
and Cosmetic Act (Act) that do not require approval of a premisions of the Act . T and Cosmetic Act (Act) that do not require approvins of the general controls of the Act. The You may, therefore, market the devices, seejos, so the may be annual registration, listing of the general controls provisions of the Fee labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it if your device is classified (see above) mis existing major regulations affecting your device can
may be subject to such additional controls. Existing major regulation FDA may be subject to such additional controller Entroling may of the 200 to 898. In addition, FDA may be found in the Code of Peachar Region Registering your device in the Federal Register.
{3}------------------------------------------------
Page 2 – Mr. Allen Izadpanah
Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that I Dri s issuation of a complies with other requirements of the Act that I DA has Inade a decommancia an administered by other Federal agencies. You must of any redelal statutes and regulations and limited to: registration and listing (21 Compry with an the Act 81equirements, as a manufacturing practice requirements as set CTN in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic forni in the quality systems (Sections 531-542 of the Act); 21 CFR 1000-1050. product ladiation control provisions (ovetice as described in your Section 510(k) This letter will anow you to begin manical equivalence of your device of your device to a legally premits thousandin. The PDF maining of castination for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific advice for Jour ac (301) 594-4648. Also, please note the regulation entitled, Colliation of Compulation and (21 the Part 807.97). You may obtain Missionaling of Icrelected to promance robilities under the Act from the Division of Small other general informational and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
B. Zimmer for
D. Z. Zimmerman, M.D.
Bran D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Attachment 2
Indications for Use
510(k) Number (if known): K043368
Device Name: ViTelCare TM Turtle 400 Patient Monitoring System
Indications for Use: ViTelCare™ Turtle 400 Patient Monitoring System is intended to be a communication tool for an in-home patient that acquires, accumulates, and transmits vital signs information, self-assessment of physical condition, and other physiological data to a healthcare practitioner located remotely from the patient. The patient information is received and stored on the MedVizer™ ViTelCare Call Center where a qualified healthcare practitioner can review the patient information and data. The communication connectivity between patient and healthcare practitioner is via a standard public telecommunications utility to the Internet. Decisions concerning diagnosis and treatment are to be performed by qualified healthcare professionals.
Prescription Use _____________________________________________________________________________________________________________________________________________________________
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page 1 of 1
B. Simmons
Division of Cardio 510(k) Number
§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).
(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).